Literature DB >> 18498239

Detection of epithelial-cell injury, and quantification of infection, in the HCT-8 organoid model of cryptosporidiosis.

Cirle Alcantara Warren1, Raul V Destura, Jesus Emmanuel A D Sevilleja, Luis F Barroso, Humberto Carvalho, Leah J Barrett, Alison D O'Brien, Richard L Guerrant.   

Abstract

BACKGROUND: Intestinal cells grown in microgravity produce a three-dimensional tissue assembly, or "organoid," similar to the human intestinal mucosa, making it an ideal model for enteric infections such as cryptosporidiosis.
METHODS: HCT-8 cells were grown in a reduced-gravity, low-shear, rotating-wall vessel (RWV) and were infected with Cryptosporidium parvum oocysts. Routine and electron microscopy (EM), immunolabeling with fluorescein-labeled Vicia villosa lectin and phycoerythrin-labeled monoclonal antibody to a 15-kD surface-membrane protein, and quantitative polymerase chain reaction (qPCR) using probes for 18s rRNA of C. parvum and HCT-8 cells were performed.
RESULTS: The RWV allowed development of columnar epithelium-like structures. Higher magnification revealed well-developed brush borders at the apical side of the tissue. Incubation with C. parvum resulted in patchy disruption of the epithelium and, at the surface of several epithelial cells, in localized infection with the organism. EM revealed irregular stunting of microvilli, foci of indistinct tight junctions, and areas of loose paracellular spaces. qPCR showed a 1.85-log (i.e., 70-fold) progression of infection from 6 h to 48 h of incubation.
CONCLUSION: The HCT-8 organoid displayed morphologic changes indicative of successful and quantifiable infection with C. parvum. The HCT-8 organoid-culture system may have application in interventional in vitro studies of cryptosporidiosis.

Entities:  

Mesh:

Year:  2008        PMID: 18498239      PMCID: PMC2631281          DOI: 10.1086/588819

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  31 in total

Review 1.  Pathogenesis of Cryptosporidium parvum infection.

Authors:  F Laurent; D McCole; L Eckmann; M F Kagnoff
Journal:  Microbes Infect       Date:  1999-02       Impact factor: 2.700

2.  A three-dimensional tissue culture model for the study of attach and efface lesion formation by enteropathogenic and enterohaemorrhagic Escherichia coli.

Authors:  Humberto M Carvalho; Louise D Teel; Gertrud Goping; Alison D O'Brien
Journal:  Cell Microbiol       Date:  2005-12       Impact factor: 3.715

Review 3.  Growing tissues in microgravity.

Authors:  B R Unsworth; P I Lelkes
Journal:  Nat Med       Date:  1998-08       Impact factor: 53.440

4.  Lymphocyte trafficking and HIV infection of human lymphoid tissue in a rotating wall vessel bioreactor.

Authors:  L B Margolis; W Fitzgerald; S Glushakova; S Hatfill; N Amichay; B Baibakov; J Zimmerberg
Journal:  AIDS Res Hum Retroviruses       Date:  1997-11-01       Impact factor: 2.205

5.  Three-dimensional organotypic models of human colonic epithelium to study the early stages of enteric salmonellosis.

Authors:  Kerstin Höner zu Bentrup; Rajee Ramamurthy; C Mark Ott; Kamal Emami; Mayra Nelman-Gonzalez; James W Wilson; Emily G Richter; Thomas J Goodwin; J Stephen Alexander; Duane L Pierson; Neal Pellis; Kent L Buchanan; Cheryl A Nickerson
Journal:  Microbes Infect       Date:  2006-04-27       Impact factor: 2.700

6.  Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid in placental malaria.

Authors:  J G Beeson; S J Rogerson; B M Cooke; J C Reeder; W Chai; A M Lawson; M E Molyneux; G V Brown
Journal:  Nat Med       Date:  2000-01       Impact factor: 53.440

7.  A549 lung epithelial cells grown as three-dimensional aggregates: alternative tissue culture model for Pseudomonas aeruginosa pathogenesis.

Authors:  A J Carterson; K Höner zu Bentrup; C M Ott; M S Clarke; D L Pierson; C R Vanderburg; K L Buchanan; C A Nickerson; M J Schurr
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

8.  Mucosal injury and disruption of intestinal barrier function in HIV-infected individuals with and without diarrhea and cryptosporidiosis in northeast Brazil.

Authors:  A A Lima; T M Silva; A M Gifoni; L J Barrett; I T McAuliffe; Y Bao; J W Fox; D P Fedorko; R L Guerrant
Journal:  Am J Gastroenterol       Date:  1997-10       Impact factor: 10.864

9.  Detection and quantification of Cryptosporidium in HCT-8 cells and human fecal specimens using real-time polymerase chain reaction.

Authors:  Jonathan B Parr; Jesus Emmanuel Sevilleja; Amidou Samie; Samie Amidou; Cirle Alcantara; Suzanne E Stroup; Anita Kohli; Ron Fayer; Aldo A M Lima; Eric R Houpt; Richard L Guerrant
Journal:  Am J Trop Med Hyg       Date:  2007-05       Impact factor: 2.345

10.  A clinicopathologic analysis of AIDS-related cryptosporidiosis.

Authors:  J A Lumadue; Y C Manabe; R D Moore; P C Belitsos; C L Sears; D P Clark
Journal:  AIDS       Date:  1998-12-24       Impact factor: 4.177

View more
  32 in total

Review 1.  Organotypic 3D cell culture models: using the rotating wall vessel to study host-pathogen interactions.

Authors:  Jennifer Barrila; Andrea L Radtke; Aurélie Crabbé; Shameema F Sarker; Melissa M Herbst-Kralovetz; C Mark Ott; Cheryl A Nickerson
Journal:  Nat Rev Microbiol       Date:  2010-11       Impact factor: 60.633

Review 2.  Modeling Host-Pathogen Interactions in the Context of the Microenvironment: Three-Dimensional Cell Culture Comes of Age.

Authors:  Jennifer Barrila; Aurélie Crabbé; Jiseon Yang; Karla Franco; Seth D Nydam; Rebecca J Forsyth; Richard R Davis; Sandhya Gangaraju; C Mark Ott; Carolyn B Coyne; Mina J Bissell; Cheryl A Nickerson
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

3.  Prolonged NF-κB activation by a macrophage inhibitory cytokine 1-linked signal in enteropathogenic Escherichia coli-infected epithelial cells.

Authors:  Hye Jin Choi; Juil Kim; Kee Hun Do; Seong-Hwan Park; Yuseok Moon
Journal:  Infect Immun       Date:  2013-02-12       Impact factor: 3.441

Review 4.  Microgravity as a biological tool to examine host-pathogen interactions and to guide development of therapeutics and preventatives that target pathogenic bacteria.

Authors:  Ellen E Higginson; James E Galen; Myron M Levine; Sharon M Tennant
Journal:  Pathog Dis       Date:  2016-09-13       Impact factor: 3.166

5.  Epithelial Cholesterol Deficiency Attenuates Human Antigen R-linked Pro-inflammatory Stimulation via an SREBP2-linked Circuit.

Authors:  Seong-Hwan Park; Juil Kim; Mira Yu; Jae-Hong Park; Yong Sik Kim; Yuseok Moon
Journal:  J Biol Chem       Date:  2016-10-04       Impact factor: 5.157

6.  Enhanced wound healing by recombinant Escherichia coli Nissle 1917 via human epidermal growth factor receptor in human intestinal epithelial cells: therapeutic implication using recombinant probiotics.

Authors:  Hye Jin Choi; Jung Hoon Ahn; Seong-Hwan Park; Kee Hun Do; Juil Kim; Yuseok Moon
Journal:  Infect Immun       Date:  2011-12-19       Impact factor: 3.441

7.  Cryptosporidium-malnutrition interactions: mucosal disruption, cytokines, and TLR signaling in a weaned murine model.

Authors:  Lourrany B Costa; Eric A JohnBull; Jordan T Reeves; Jesus Emmanuel Sevilleja; Rosemayre S Freire; Paul S Hoffman; Aldo A M Lima; Reinaldo B Oriá; James K Roche; Richard L Guerrant; Cirle Alcantara Warren
Journal:  J Parasitol       Date:  2011-06-28       Impact factor: 1.276

8.  Gut-microbiota-on-a-chip: an enabling field for physiological research.

Authors:  Grissel Trujillo-de Santiago; Matías José Lobo-Zegers; Silvia Lorena Montes-Fonseca; Yu Shrike Zhang; Mario Moisés Alvarez
Journal:  Microphysiol Syst       Date:  2018-10-16

9.  An update to space biomedical research: tissue engineering in microgravity bioreactors.

Authors:  Abolfazl Barzegari; Amir Ata Saei
Journal:  Bioimpacts       Date:  2012-03-16

10.  Development of a Multicellular Three-dimensional Organotypic Model of the Human Intestinal Mucosa Grown Under Microgravity.

Authors:  Rosangela Salerno-Goncalves; Alessio Fasano; Marcelo B Sztein
Journal:  J Vis Exp       Date:  2016-07-25       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.